Abstract LB155: Durable anti-tumor immunity through in vivo CAR T cell engineering using the RetroT all-RNA genome integration platform
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154709785
Cites:
Cited by:
Related to:
